Disc Medicine Inc
(IRON)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,781 | -46,827 | -35,583 | -19,433 | -9,853 |
| Depreciation Amortization | 25 | 89 | 64 | 40 | 18 |
| Accounts payable and accrued liabilities | -10,750 | 526 | 600 | 1,003 | -982 |
| Other Working Capital | -13,818 | 2,125 | -1,743 | -1,773 | -4,172 |
| Other Operating Activity | 11,858 | 1,835 | 4,075 | -2,732 | 1,288 |
| Operating Cash Flow | $-35,466 | $-42,252 | $-32,587 | $-22,895 | $-13,701 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -29 | -151 | -139 | -120 | -100 |
| Investing Cash Flow | $-29 | $-151 | $-139 | $-120 | $-100 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 77,306 | 151,122 | 163 | 141 | 55 |
| Other Financing Activity | 0 | -2,144 | 0 | 0 | 0 |
| Financing Cash Flow | $77,306 | $148,978 | $163 | $141 | $55 |
| Beginning Cash Position | 194,788 | 88,213 | 88,213 | 88,213 | 88,213 |
| End Cash Position | 236,599 | 194,788 | 55,650 | 65,339 | 74,467 |
| Net Cash Flow | $41,811 | $106,575 | $-32,563 | $-22,874 | $-13,746 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,466 | -42,252 | -32,587 | -22,895 | -13,701 |
| Capital Expenditure | -29 | -151 | -139 | -120 | -100 |
| Free Cash Flow | -35,495 | -42,403 | -32,726 | -23,015 | -13,801 |